Urology
Volume 68, Issue 4 , Pages 741-746 , October 2006

Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma

  • Alexander S. Parker

      Affiliations

    • Department of Urology, Mayo Clinic Jacksonville, Jacksonville, Florida
    • Corresponding Author InformationReprint requests: Alexander S. Parker, Ph.D., Department of Urology, Mayo Clinic Jacksonville, Davis 3E, 4500 San Pablo Road, Jacksonville, FL 32224.
  • ,
  • Christine M. Lohse

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic Rochester, Rochester, Minnesota, USA
  • ,
  • John C. Cheville

      Affiliations

    • Department of Anatomic Pathology, Mayo Clinic Rochester, Rochester, Minnesota, USA
  • ,
  • David D. Thiel

      Affiliations

    • Department of Urology, Mayo Clinic Jacksonville, Jacksonville, Florida
  • ,
  • Bradley C. Leibovich

      Affiliations

    • Department of Urology, Mayo Clinic Rochester, Rochester, Minnesota
  • ,
  • Michael L. Blute

      Affiliations

    • Department of Urology, Mayo Clinic Rochester, Rochester, Minnesota

Received 17 February 2006 ,Accepted 24 May 2006.

References 

  1. Bergstrom A, Hsieh CC, Lindblad P, et al. Obesity and renal cell cancer—a quantitative review. Br J Cancer. 2001;85:984–990
  2. Murai M, Oya M. Renal cell carcinoma: etiology, incidence and epidemiology. Curr Opin Urol. 2004;14:229–233
  3. Yu ML, Asal NR, Geyer JR. Later recurrence and longer survival among obese patients with renal cell carcinoma. Cancer. 1991;68:1648–1655
  4. Kamat AM, Shock RP, Naya Y, et al. Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors. Urology. 2004;63:46–50
  5. Schips L, Lipsky K, Zigeuner R, et al. Does overweight impact on the prognosis of patients with renal cell carcinoma? (A single center experience of 683 patients). J Surg Oncol. 2004;88:57–61
  6. Donat S, Salzhauer E, Mitra N, et al. Impact of body mass index on survival of patients with surgically treated renal cell carcinoma. J Urol. 2006;175:46–52
  7. Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 2003;27:612–624
  8. Amin MB, Amin MB, Tamboli P, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol. 2002;26:281–291
  9. Frank I, Blute ML, Cheville JC, et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade, and necrosis: the SSIGN score. J Urol. 2002;168:2395–2400
  10. Lee CT, Dunn RL, Chen BT, et al. Impact of body mass index on radical cystectomy. J Urol. 2004;172(4 Pt 1):1281–1285
  11. Hafron J, Mitra N, Dalbagni G, et al. Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?. J Urol. 2005;173:1513–1517
  12. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–1638
  13. Amling CL, Riffenburgh RH, Sun L, et al. Obesity and race predict adverse pathologic variables and higher recurrence rates in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol. 2004;22:439–445
  14. Amling CL, Riffenburgh RH, Sun L, et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol. 2004;22:439–445
  15. Freedland SJ, Aronson WJ, Kane CJ, et al. Impact of obesity on biochemical control following radical prostatectomy for clinically localized prostate cancer. J Clin Oncol. 2004;22:446–453
  16. Mallah KN, DiBlasio CJ, Rhee AC, et al. Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy. Cancer. 2005;103:2030–2034

PII: S0090-4295(06)00738-2

doi: 10.1016/j.urology.2006.05.024

Urology
Volume 68, Issue 4 , Pages 741-746 , October 2006